U.S. patent application number 15/103377 was filed with the patent office on 2016-10-27 for selectable dose injection device with latch mechanism.
The applicant listed for this patent is OWEN MUMFORD LIMITED. Invention is credited to Joe David COWAN, Matthew FARMER, Elizabeth MACDONALD, Lee Thomas SMITH.
Application Number | 20160310673 15/103377 |
Document ID | / |
Family ID | 50030916 |
Filed Date | 2016-10-27 |
United States Patent
Application |
20160310673 |
Kind Code |
A1 |
MACDONALD; Elizabeth ; et
al. |
October 27, 2016 |
SELECTABLE DOSE INJECTION DEVICE WITH LATCH MECHANISM
Abstract
A substance delivery device for delivering a substance from a
container includes a body, and a plunger movable with respect to
the body so as to expel at least a portion of a substance from the
container, a trigger mechanism, a latch member latched in a
stationary position at least along the longitudinal axis of the
device before use, and a lockout shroud movable along the
longitudinal axis relative to the latch mechanism. User
manipulation of the trigger mechanism causes the latch mechanism to
become unlatched and move along the longitudinal axis and to cause
movement of a plunger relative to the body, and in a first position
of the lockout shroud along the longitudinal axis relative to the
latch member, the lockout shroud prevents the trigger mechanism
from unlatching the latch member, whereas in a second position the
lockout shroud allows the trigger mechanism to unlatch the latch
member.
Inventors: |
MACDONALD; Elizabeth;
(Chichester, GB) ; SMITH; Lee Thomas; (Stafford,
GB) ; COWAN; Joe David; (Staffordshire, GB) ;
FARMER; Matthew; (Oxfordshire, GB) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
OWEN MUMFORD LIMITED |
Woodstock, Oxfordshire |
|
GB |
|
|
Family ID: |
50030916 |
Appl. No.: |
15/103377 |
Filed: |
December 12, 2014 |
PCT Filed: |
December 12, 2014 |
PCT NO: |
PCT/GB2014/053696 |
371 Date: |
June 10, 2016 |
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61M 5/31553 20130101;
A61M 2005/2013 20130101; A61M 5/3155 20130101; A61M 5/3153
20130101; A61M 2005/206 20130101; A61M 5/3204 20130101; A61M
5/31525 20130101; A61M 5/3213 20130101; A61M 5/2033 20130101; A61M
5/31578 20130101; A61M 2005/2403 20130101; A61M 5/24 20130101; A61M
2005/208 20130101; A61M 5/31591 20130101; A61M 2005/2073 20130101;
A61M 5/31501 20130101; A61M 2005/3125 20130101; A61M 5/3158
20130101; A61M 5/5086 20130101; A61M 5/3156 20130101; A61M
2005/3247 20130101 |
International
Class: |
A61M 5/315 20060101
A61M005/315; A61M 5/24 20060101 A61M005/24; A61M 5/20 20060101
A61M005/20; A61M 5/32 20060101 A61M005/32 |
Foreign Application Data
Date |
Code |
Application Number |
Dec 13, 2013 |
GB |
1322110.6 |
Claims
1-18. (canceled)
19. A substance delivery device for delivering a substance from a
container, the device comprising a body, a plunger which is movable
with respect to the body so as to expel at least a portion of a
substance from a container, a trigger mechanism, a latch member
latched in a stationary position at least along the longitudinal
axis of the device before use, a lockout shroud being moveable
along the longitudinal axis relative to the latch mechanism,
wherein user manipulation of the trigger mechanism causes the latch
member to become unlatched and able to move along the longitudinal
axis and to enable movement of a plunger relative to the body, and
in a first position of the lockout shroud along the longitudinal
axis relative to the latch member, the lockout shroud prevents the
trigger mechanism from unlatching the latch member, whereas in a
second position the lockout shroud allows the trigger mechanism to
unlatch the latch member.
20. The substance delivery device as claimed in claim 19 wherein
the lockout shroud comprises one or more members configured, when
the lockout shroud is in the first position, to prevent movement of
one or more portions of the latch member, which in turn prevents
the trigger mechanism from unlatching the latch member.
21. The substance delivery device as claimed in claim 19, wherein a
needle guard is accommodated at one end of the lockout shroud.
22. The substance delivery device as claimed in claim 21, wherein
before use of the device the end of the lockout shroud stands proud
of the needle guard and after the device is fired, the needle guard
is retained by the lockout shroud but stands proud of the end of
the lockout shroud.
23. The substance delivery device as claimed in claim 19, wherein
the degree of movement between the plunger and the body determines
the amount of substance that is delivered and the device comprises,
an instance of one or more co-operating features associated with
the plunger, and a corresponding instance of one or more
co-operating features associated with the body, whereby
co-operation between the two instances of co-operating features
determines the degree of movement between the plunger and the body,
wherein there is a plural instances of said one or more
co-operating features associated with at least one of the plunger
and the body, and co-operation between different instances of
co-operating features allows different ranges of movement between
the plunger and the body.
24. The substance delivery device as claimed in claim 23, wherein
there is a single instance of one or more co-operating features
associated with one of the body and the plunger and plural
instances of one or more co-operating features associated with the
other of the plunger and the body.
25. The substance delivery device as claimed in claim 23, wherein
the at least one instance of one or more co-operating features
associated with the plunger is located on an external surface of
the plunger.
26. The substance delivery device as claimed in claim 23, wherein
the at least one instance of one or more co-operating features
associated with the body is located on an internal surface of the
body.
27. The substance delivery device as claimed in claim 23, wherein
the plural instances of one or more co-operating features
associated with one of the plunger and the body each comprise one
or more tracks, and the or each track of a first instance of the
one or more co-operating features is relatively long compared with
the or each track of a further instance of the co-operating
features.
28. The substance delivery device as claimed in claim 27, wherein a
single instance of one or more co-operating features comprises an
instance of one or more pegs associated with one of the plunger and
the body, the or each peg configured to follow each said track.
29. The substance delivery device as claimed in claim 23, wherein
relative rotation of the plunger and body determines which instance
of one or more co-operating features associated with the body or
the plunger is selected for co-operation with the corresponding
instance of at least one co-operating feature associated with the
other of the body and the plunger.
30. The substance delivery device as claimed in claim 29, wherein
the device further comprises a selector rotatable by a user for
causing relative rotation of the plunger relative to the body.
31. The substance delivery device as claimed in claim 19 and
comprising a container carrier housed within the body for receiving
a substance container, wherein the container carrier is move-able
along a longitudinal axis of the device relative to the body during
a substance delivery process, wherein a surface of the container
carrier includes at least one visual indicator that can be seen
through a window in the body in at least one of the positions of
the container carrier.
32. The substance delivery device as claimed in claim 31, wherein
the container carrier carries two visual indicators, at least one
of the visual indicators is not visible to a user in at least one
position of the container carrier.
33. The substance delivery device as claimed in claim 31, wherein
the lockout shroud is housed coaxially within the body of the
device, the container carrier being housed within the lockout
shroud and the lockout shroud comprises a cut out portion whereby a
portion of the container carrier can be seen through the window of
the body.
34. A substance delivery device for delivering a substance from a
container, the device comprising a body, a plunger which is movable
with respect to the body so as to expel at least a portion of a
substance from a container, a container carrier housed within the
body for receiving a substance container, wherein the container
carrier is move-able along a longitudinal axis of the device
relative to the body during a substance delivery process, wherein
and a surface of the container carrier includes at least one visual
indicator that can be seen through a window in the body in at least
one of the positions of the container carrier.
35. The substance delivery device as claimed in claim 34, wherein
the container carrier carries two visual indicators, at least one
of the visual indicators is not visible to a user in at least one
position of the container carrier.
36. The substance delivery device as claimed in claim 34, further
comprising a lockout shroud housed coaxially within the body of the
device, the container carrier being housed within the lockout
shroud and the lockout shroud comprises a cut out portion whereby a
portion of the container carrier can be seen through the window of
the body.
Description
TECHNICAL FIELD
[0001] The present invention relates to injection devices with a
mechanical interlock and, in particular, though not necessarily, to
such injection devices for delivering a single dose of
medicament.
BACKGROUND
[0002] WO-A-03/011378 discloses an injection device where a syringe
is enclosed in a housing of barrel-like form, the syringe being
propelled forward by a drive mechanism to project its needle,
followed by continued operation of the drive mechanism to push the
plunger of the syringe and eject a dose. This procedure will leave
the needle sticking-out, unless certain measures are taken. One
answer is to have an arrangement for withdrawing the syringe back
into the housing, while another is to have a needle shroud that
moves out from the housing to enclose the-needle. Of course, this
must not interfere with the actual injection operation. It has
therefore been proposed that the shroud is normally spring urged
forwardly to a needle protecting position, but when the device is
pushed against the patient's skin the shroud is forced to retract
against its spring. After injection, the spring pushes the shroud
forwards again. A mechanism is provided for automatically locking
the shroud at its fully projecting position after the injection but
not before. The device of WO-A-03/011378 comprises a housing for
the syringe, a needle-shroud captive to the leading end of the
housing and movable before use between extended and retracted
positions, a drive member releasable from a rearward position
within the housing to urge the syringe forwards to project its
needle beyond the retracted needle shroud and then to express a
dose through the needle, and locating members on the housing for
capturing the drive member at its forward position attained after
expressing the dose, and wherein the captured drive member is
arranged to block retraction of the needle shroud from its extended
position.
[0003] EP-A-1968670 discloses a substance delivery device
(auto-injector) for use with a container (such as a syringe)
containing the substance, the device comprising a body arranged to
house or hold the container; a plunger which is movable with
respect to at least a portion of the body, the plunger being
arranged to act upon the container so as to move the container with
respect to said portion of the body; wherein the plunger is also
arranged to expel at least a portion of the substance from the
container; and wherein the device comprises means for adjusting the
amount of substance to be expelled from the container. The device
can also have means for priming the container, and can accommodate
containers of different size or shape.
[0004] FIG. 6 is a sectional view of an embodiment of the device
disclosed in EP-A-1968670. The injection device 1 comprises a body
or housing 2, which has three portions. These are (in the order
from the proximal end of device 1 to the distal end): a main body
10, a mid-body 13 and a shroud retainer 15, the main body 10 is
subdivided into a proximal main body portion 11 and a distal main
body portion 12. These portions can be formed as one piece. The
housing 2 carries or houses a sleeve-like syringe carrier 82, which
is an example of a container carrier. The syringe carrier 82 in
turn carries a syringe 20 (or other container for a substance).
Syringe 20 comprises a generally cylindrical container portion 24
for accommodating a fluid 22, and a cannula 26. The needle is in
communication with the interior of container portion 24 so that the
fluid 22 may be expelled through cannula 26. A bung 28 is inserted
in the container portion 24 at the proximal end. The bung 28 seals
the fluid 22 within the container portion 24. Syringe 20 is biased
towards the proximal end by means of spring 23. This spring 23 is
however relatively weak. Cannula 26 is initially protected by a
needle sheath 29.
[0005] A safety cap or needle sheath remover 30 is provided at the
distal end of injection device 1. This safety cap 30 is carried by
the shroud retainer 15 of housing 2.
[0006] Towards its proximal end the safety cap 30 is hooked over
the proximal end of needle sheath 29 so that, when safety cap 30 is
removed, the needle sheath is removed as well.
[0007] The distal end of injection device 1 is also provided with a
needle guard 32 or "lockout shroud". This needle guard 32 is
moveable along the longitudinal axis of the injection device over a
limited range. The needle guard 32 is initially covered, and
prevented from moving, by safety cap 30. Only once safety cap 30
has been removed (as will be explained below) can needle guard 32
move.
[0008] Towards the proximal end of injection device 1 there is
provided a plunger 40, which has a distal portion 41 and a proximal
portion 42. The plunger is biased by spring 50 towards the distal
direction. This bias is relatively strong, and much stronger than
the bias provided by spring 23.
[0009] At the very proximal end of injection device 1 there is
provided a firing button assembly. Its structure and function will
be explained below.
[0010] The core principle of operation and much of the structure of
the injection device 1 is very similar to the technique disclosed
in WO 03/011378. Essentially, as in that earlier document, after
removal of the safety cap 30 (and needle sheath 29) the needle
guard 32 extends in distal direction because of the bias provided
by a spring 34. The distal end of the injection device 1 is then
pressed against a patient's skin. This pushes needle guard 32 in
proximal direction against the bias of spring 34. However, during
this action the cannula 26 does not project beyond the distal end
of needle guard 32.
[0011] As in the earlier-disclosed technique, when the firing
button is depressed the plunger 40 is released and can move in
distal direction. When the front surface 45 of plunger 40 contacts
bung 28, continued movement of the plunger in distal direction
initially moves syringe 20 (i.e. not just bung 28) in distal
direction. This is so because the force required to move bung 28 in
distal direction with respect to container portion 24 is greater
than the force required to move the entire syringe 20 in distal
direction (to this end the interior surface of the container
portion 24 can be provided with circumferential ribs or other
friction increasing formations). During this movement of syringe 20
the cannula 26 penetrates the skin of the patient. Eventually the
movement in distal direction of syringe 20 comes to a halt, but
plunger 40 is still able to move further in distal direction. This
leads to bung 28 being moved in distal direction with respect to
container portion 24, which means that fluid 22 is expelled from
container portion 24 through cannula 26 into the patient. Hence the
movement of the syringe 20 (as a whole) and the movement of bung 28
within syringe 20 is brought about by plunger 40 acting on bung 28.
It will be appreciated that the portion of plunger 40 (i.e. distal
end surface 45) which acts on the syringe 20 to move the syringe is
the same as the portion of the plunger which acts on the syringe to
move bung 28 so as to expel the fluid. When the plunger 40 has its
movement in distal direction stopped the injection operation has
been completed. The user can then move the injection device 1 in
proximal direction so as to withdraw the needle from the injection
site. As the injection device 1 is withdrawn from the skin of the
patient the needle guard 32 is moved in distal direction due to the
bias provided by spring 34. The guard 32 then locks in the distal
position rendering the device safe. The injection device 1 can then
be disposed of.
[0012] In contrast to the earlier-disclosed injection device,
EP-A-1968670 discloses several additional features. Most notably
these additional features are an adjustment means for adjusting the
dose to be injected, and a priming function.
[0013] The adjustment means of EP-A-1968670 primarily comprises a
stop member 44 carried by the distal plunger portion 41. Stop
member 44 may be provided with an internal thread co-operating with
an external thread 43 on the circumferential surface of the distal
plunger portion 41. Additionally, stop member 44 is keyed at 46 to
the inner surface of distal housing portion 12. With stop member 44
being threadably engaged with the distal plunger portion 41 and
being keyed to distal housing portion 12 (e.g. by means of splines
or similar, not shown), the stop member 44 will move in distal or
proximal direction when distal plunger portion 41 is rotated about
its longitudinal axis.
[0014] Distal plunger portion 41 can be rotated by means of
adjustment ring 48. Adjustment ring 48 is keyed to a relatively
large diameter proximal portion 49 of the plunger 40. This means
that, on rotation of adjustment ring 48, the distal plunger portion
41 will carry out the same rotation, but the distal plunger portion
41 is substantially free to move in a direction parallel to the
plunger axis, independently from adjustment ring 48. The proximal
portion 49 of the distal plunger portion 41 is engaged with the
distal portion 47 of the proximal plunger portion 42 such that the
distal plunger portion 41 can substantially freely rotate with
respect to the proximal plunger portion 42 but has to make the same
movements in distal or proximal direction as the proximal plunger
portion 42.
[0015] The adjustment ring 48 is located between proximal and
distal main body portions 11 and 12. Windows 14 are provided on
opposite sides of main body 10 where the proximal and distal main
body portions 11 and 12 meet.
[0016] The injection device 1 has a generally oval cross section.
The windows 14 are provided on those "sides" of the oval which have
the smaller distance from the centre of the oval. The main body is
continuous on those "sides" of the oval which have the greatest
distance from the centre of the oval. This means that the main body
10 with proximal and distal main body portions 11 and 12 can be
formed (e.g. moulded) in one piece and further that adjustment ring
48 can project through windows 14 whilst being securely held within
main body 10.
[0017] In order to adjust the dose to be injected the user can
rotate adjustment ring 48, thereby rotating the plunger 40. As
mentioned, this sets the axial position of stop member 44 along
distal plunger portion 41. Through setting this axial position the
user can determine how far the plunger is allowed to project into
container portion 24. This is so because movement of the plunger in
distal direction during the injection process is stopped when stop
member 44 makes contact with the proximal end of container portion
24. The axial position of stop member 44 along distal plunger
portion 41 (before the beginning of the injection operation) can be
viewed by the user through a further window 16 provided in the
distal main body portion 12. Suitable indications may be provided
at window 16 to indicate to the user which dose corresponds to the
set position of stop member 44 with respect to window 16.
[0018] EP-A-2633874 discloses a medicament delivery device
comprising a housing, a safety sleeve movable between an extended
position and a retracted position relative to the housing, a guide
sleeve rotatably disposed in the housing, a plunger slidably
disposed in the safety sleeve, and a button coupled to the housing.
When the safety sleeve is in the retracted position, translation of
the button relative to the housing causes the guide sleeve to
rotate relative to the safety sleeve. Rotation of the guide sleeve
relative to the safety sleeve allows the plunger to translate a
predetermined axial distance relative to the safety sleeve.
SUMMARY
[0019] In a first aspect the invention provides a substance
delivery device for delivering a substance from a container, the
device comprising a body, a plunger which is movable with respect
to the body so as to expel at least a portion of a substance from a
container, a trigger mechanism, a latch member latched in a
stationary position at least along the longitudinal axis of the
device before use, a lockout shroud being moveable along the
longitudinal axis relative to the latch mechanism, wherein user
manipulation of the trigger mechanism causes the latch mechanism to
become unlatched and able to move along the longitudinal axis and
to cause movement of a plunger relative to the body, and in a first
position of the lockout shroud along the longitudinal axis relative
to the latch member, the lockout shroud prevents the trigger
mechanism from unlatching the latch member, whereas in a second
position the lockout shroud allows the trigger mechanism to unlatch
the latch member.
[0020] The lockout shroud may comprise one or more members
configured, when the lockout shroud is in the first position, to
prevent movement of one or more portions of the latch member, which
in turn prevents the trigger mechanism from unlatching the latch
member.
[0021] A needle guard may be accommodated at one end of the lockout
shroud.
[0022] Before use of the device the end of the lockout shroud may
stand proud of the needle guard and after the device is fired, the
needle guard is retained by the lockout shroud but stands proud of
the end of the lockout shroud.
[0023] The degree of movement between the plunger and the body may
determine the amount of substance that is delivered and the device
may comprises, an instance of one or more co-operating features
associated with the plunger, and a corresponding instance of one or
more co-operating features associated with the body, whereby
co-operation between the two instances of co-operating features
determines the degree of movement between the plunger and the body,
wherein there is a plural instances of said one or more
co-operating features associated with at least one of the plunger
and the body, and co-operation between different instances of
co-operating features allows different ranges of movement between
the plunger and the body.
[0024] There may be a single instance of one or more co-operating
features associated with one of the body and the plunger and plural
instances of one or more co-operating features associated with the
other of the plunger and the body.
[0025] The at least one instance of one or more co-operating
features associated with the plunger may be located on an external
surface of the plunger.
[0026] The at least one instance of one or more co-operating
features associated with the body may be located on an internal
surface of the body.
[0027] The plural instances of one or more co-operating features
associated with one of the plunger and the body may each comprise
one or more tracks, and the or each track of a first instance of
the one or more co-operating features may be relatively long
compared with the or each track of a further instance of the
co-operating features.
[0028] A single instance of one or more co-operating features may
comprise an instance of one or more pegs associated with one of the
plunger and the body, the or each peg being configured to follow
each said track.
[0029] Relative rotation of the plunger and body may determines
which instance of one or more co-operating features associated with
the body or the plunger is selected for co-operation with the
corresponding instance of at least one co-operating feature
associated with the other of the body and the plunger.
[0030] The device may further comprise a selector rotatable by a
user for causing relative rotation of the plunger relative to the
body.
[0031] The substance delivery device may comprise a container
carrier housed within the body for receiving a substance container,
wherein the container carrier is move-able along a longitudinal
axis of the device relative to the body during a substance delivery
process, wherein a surface of the container carrier includes at
least one visual indicator that can be seen through a window in the
body in at least one of the positions of the container carrier.
[0032] The container carrier may carry two visual indicators, at
least one of the visual indicators is not visible to a user in at
least one position of the container carrier.
[0033] The lockout shroud may be housed coaxially within the body
of the device, the container carrier being housed within the
lockout shroud and the lockout shroud comprises a cut out portion
whereby a portion of the container carrier can be seen through the
window of the body.
[0034] In a second aspect the invention provides a substance
delivery device for delivering a substance from a container, the
device comprising a body, a plunger which is movable with respect
to the body so as to expel at least a portion of a substance from a
container, a container carrier housed within the body for receiving
a substance container, wherein the container carrier is move-able
along a longitudinal axis of the device relative to the body during
a substance delivery process, wherein and a surface of the
container carrier includes at least one visual indicator that can
be seen through a window in the body in at least one of the
positions of the container carrier.
[0035] The container carrier may carry two visual indicators, at
least one of the visual indicators is not visible to a user in at
least one position of the container carrier.
[0036] The substance delivery device may further comprise a lockout
shroud housed coaxially within the body of the device, the
container carrier being housed within the lockout shroud and the
lockout shroud comprises a cut out portion whereby a portion of the
container carrier can be seen through the window of the body.
BRIEF DESCRIPTION OF THE DRAWINGS
[0037] FIG. 1 is a cross section through an injection device
according to the invention;
[0038] FIG. 2 is an exploded perspective view of a proximal portion
of the device of FIG. 1;
[0039] FIG. 3 is an exploded perspective view of a distal portion
of the device of FIG. 1;
[0040] FIGS. 4a and 4b are detailed part views of the lockout
shroud and latch ring;
[0041] FIG. 5 is a perspective view of the device of FIG. 1;
[0042] FIG. 6 is a cross section through a prior art injector
pen;
DETAILED DESCRIPTION
[0043] Considering FIGS. 1 to 5, an injection device 1 is shown in
accordance with the invention. FIG. 1 is a cross section through
the whole device whereas FIGS. 2 and 3 are exploded perspective
views of certain components of the device for ease of description.
FIGS. 4a and 4b are enlarged view of a portion of a lockout shroud
and a latch ring that co-operates with the lockout shroud as
described below.
[0044] As can be seen from the exploded views the various part of
the device fit together along a common longitudinal axis. The
embodiment shown is a specific embodiment and is not intend to
limit the manner in which the invention is implemented. For
example, where some parts are shown as separate but would function
mechanically if they were integral then the skilled person will
recognise that both implementations are disclosed herein; similarly
where certain parts are shown as integral but could be provided as
two or more parts then such an implementation is also envisaged as
falling within the present invention.
[0045] The main parts of the device 1 are the housing 2, including
a main body 10, a mid-body 13, a shroud retainer 15, a needle guard
32, syringe carrier 82, syringe 20 including a container portion
24, plunger 40, a dose adjuster rod 41, firing spring 50 and
trigger button 52. The dose adjuster rod in the present embodiment
is fixed both rotationally and axially to the main body 10. The
device also includes amongst other components, a lock out shroud
100 (shown in FIGS. 1 and 3) and an interlocking latch ring 110
(FIGS. 1 and 2).
[0046] Starting from the proximal end and considering FIGS. 1 and
2, a firing or trigger button 52 is received concentrically within
the main body 10, together with the dose adjuster rod 41 and the
firing spring 50. Dose adjuster rod 41 has its proximal end 43
connected to the main body 10; in this case the proximal end 43 is
received by an opening 44 in a frame 46 formed at the proximal end
of the main body 10. Rotation of the main body causes rotation of
the dose adjuster rod 41 around its longitudinal axis.
[0047] The trigger button 52 co-operates with the latch ring 110.
The latch ring 110 is held in place relative to the housing 2,
before use, by shoulder 19 carried by the internal wall of the main
body 10 of the housing 2, which co-operates with co-operating
portions in the form of outwardly projecting teeth 58 on flexible
fingers 111 of the latch ring 110. The trigger button 52 has
flexible arms 53 with cam surfaces 113 that co-operate with cam
surfaces on the flexible fingers 111 of the latch ring 110, such
that movement of the trigger button 52 relative to the latch ring
110 in the distal direction (towards the needle end of the device)
will flex the fingers 111 of the latch ring 110 inwardly releasing
the co-operating portions 58 from the shoulder 19. During the
process the trigger button moves relative to the main body 10
against the bias of a spring 54.
[0048] Once the latch ring 110 has been released during the above
process, the trigger button 52 is prevented from further,
significant, movement, distally relative to the housing 2 by the
ends of the flexible arms of the trigger button 52 abutting the
shoulder 19. Alternatively, further co-operating elements can be
supplied on the trigger button 52 or housing 2, or both in order to
prevent further movement of the trigger button on release of the
latch ring 110. The latch ring 110 is then urged forcefully by the
spring 50 in a distal direction axially of the housing 2. The latch
ring 110 in turn acts on a proximal portion of the plunger 40.
[0049] In an initial condition the above process is prevented from
occurring by the lockout shroud 100. A proximal end of the lock out
shroud cooperates with the latch ring to prevent accidental firing
of the device 1. In other words, there is a two stage firing
process, which is described below.
[0050] Turning now to FIGS. 1 and 3; distal end of plunger 40 is
received in container portion 24 of syringe 20. In turn, the
container portion 24 is received within syringe carrier 82, and
syringe carrier 82 is received within lockout shroud 100. The
syringe 20, the syringe carrier 82, and lockout shroud 100 are all
housed within the mid-body portion 13 of housing 2.
[0051] A safety cap or needle sheath remover 30 is provided at the
distal end of injection device 1. In an embodiment the safety cap
30 is hooked over the proximal end of a needle sheath 29 protecting
the needle before use so that, when safety cap 30 is removed, the
needle sheath is removed as well. The safety cap 30 may be formed
in 2 halves which are assembled around the needle sheath to avoid
applying axial force to the needle sheath during assembly. In the
present embodiment shown in FIGS. 1 and 3, a separate component 15
is provided that is formed as a claim shell or in this case half
clam shell which is assembled around the needle sheath allowing the
safety cap to be snap fit onto the component 15 without damaging
the needle sheath.
[0052] A needle guard 32 is accommodated on the distal end of the
lockout shroud 100 and is moveable therewith axially of the
mid-body 13. A spring 34 is included to bias the needle guard 32 in
a distal direction and the syringe carrier 82 in a proximal
direction.
[0053] In the present embodiment the needle guard 32 has proximally
extending legs 33 which engage with axially extending closed-ended
grooves 35 within the lockout shroud 100. The legs 33 have outward
protrusions which initially engage within deeper detents within the
grooves which hold the guard in position relative to the lockout
shroud. This allows the needle guard 32 to move a limited distance
in a distal direction only once the detent engagement has been
disengaged but to be constrained from becoming detached from the
lockout shroud 100. As can be seen from FIG. 1, with the safety cap
30 in place, the lockout shroud stands proud of the needle guard 32
which is located within the lockout shroud.
[0054] Once the safety cap 30 is removed, pressure can be applied
to the end of the lockout shroud 100 (in use by pressing the end of
the device against the skin of the user), whereby the needle guard
32 and the lockout shroud 100 move axially relative to the housing
2 in the proximal direction.
[0055] As can be seen more clearly in FIGS. 4A and 4B, the flexible
fingers 111 of the latch ring 110 are interspersed by slots which
have a generally T-shaped profile, the head of the T-profile being
at the proximal end of the latch ring 110. Before any movement of
the lockout shroud 100 in the proximal direction (FIG. 4a),
internally facing lugs 114 located at the ends of the legs 101 of
the lockout shroud 100 engage with the flexible fingers 111 of the
latch ring 110 in the region of the narrow part of the T-profile.
This arrangement prevents inward flexing of the fingers 111 and
movement of the trigger button 52 since it is necessary for the
fingers 111 to flex inwards for the trigger button to move relative
to the latch ring.
[0056] The application of sufficient pressure to the distal end of
lockout shroud 100 causes movement of the needle guard 32 and the
lockout shroud 100 relative to the housing 2. The latch ring 110 is
prevented from movement in the proximal direction (relative to the
housing 2) by its engagement with the trigger button 52 and the
force of the loaded spring 52; thus the lockout shroud 100 also
moves relative to the latch ring 110. The movement of the lockout
shroud 100 against the bias of the spring 34 is sufficient to move
the lugs 114 into the T-profile slots described by the fingers 111
of the latch ring 110 (FIG. 4b) allowing fingers 111 to flex
inwards. The trigger button can now be pushed axially of the
housing 2 in the distal direction causing the cam surfaces 113 to
co-operate with the fingers 111 to cause inward flexing of the
fingers 111 and disengaging teeth 58 from shoulder 19.
[0057] When both operations required to trigger the device to fire
are performed, the spring 50 then urges the latch ring 110 to move
distally relative to the housing 2, until it contacts the plunger
40 and then the plunger 40 is also urged forcefully in the distal
direction relative to the housing 2. The syringe 20 and syringe
carrier 82 also move relative to the housing 2, the lockout shroud
100 and consequently the needle guard 32. This movement proceeds a
certain distance increasing the pressure on the spring 34 which
acts between the syringe carrier 82 and the needle guard 32 until
the needle guard 32 is knocked out of position relative to the
lockout shroud 100 when sufficient pressure is built up in spring
34 (or the spring 34 is completely compressed becoming solid in
which case the entire load from spring 50 then acts to knock the
guard out of its detent previously keeping it in place relative to
the lockout shroud 100). The geometry is chosen to make sure the
forward movement of the syringe carrier 82 is subsequently halted
before the needle guard 32 is driven into the user under a high
force from spring 50. Forward movement of the syringe carrier 82 is
halted when one or more engagement portions 85 on the syringe
carrier 82 abut corresponding engagement portions 86 on the
internal wall of the lockout shroud 100. The force of the drive
spring 50 is then applied to the plunger 40, the syringe carrier
82, and the lockout shroud 100, whereas the needle guard 32 is
biased lightly forward by spring 34 only. Subsequent axial movement
of the plunger 40 is then relative to the container portion 24 and
causes the substance in the container to be expelled through the
cannula 26.
[0058] Removing the pressure on the distal end of the lockout
shroud 100 allows the needle guard 32 to extend beyond the lockout
shroud under bias of spring 34 so as to guard the cannula that now
extends beyond the lockout shroud 100. In the present embodiment
the syringe carrier 82 is prevented from returning to its original
position by the force of the firing spring acting on the latch
ring, the plunger, the syringe and the syringe carrier.
[0059] The above described arrangement with the interlocking latch
ring 110 and lockout shroud 100 provide a novel arrangement for a
device with a two stage firing process.
[0060] Alternatively, or in addition a latch button may be provided
external of the housing to allow firing of the device without
movement of the lockout shroud if present. Instead of moving a
lockout shroud to allow movement of fingers 111, a latch button can
effect movement of the shoulder or shoulders 19 (or a portion of
the housing carrying the shoulder 19) so as to allow movement of
the latch ring 110 relative to the housing.
[0061] The present embodiment will also be used to describe a novel
variable dosing selection for an injection device that may be used
in conjunction with the above arrangement or may be used in other
arrangements where appropriate.
[0062] As most easily seen in FIG. 2, the plunger 40 includes a
head 102 for receiving the dose adjuster rod 41. As can be seen the
distal end 103 of the dose adjuster rod 41 is shaped so as to
prevent rotation of the dose adjuster rod 41 relative to the
plunger 40. The head 102 of the plunger 40 carries pegs 104, which
are shaped to follow tracks 105 in the housing 2, principally in
the mid-body 13.
[0063] During the firing process the pegs 104 follow the tracks 105
as the plunger 40 travels axially within the housing 2. The tracks
105 are of a length to provide a specific dose of substance to be
expelled from the syringe 20. The plunger can only travel the
length of the tracks 105 before coming to a stop as the pegs 104
abut the end of the tracks 105. By providing more than one set of
tracks 105--each set of tracks providing a differing specific dose
of substance to be delivered by the device--a simple means for
selecting the dose to be delivered is provided.
[0064] Before triggering the device 1, the pegs 104 are located at
the start of one set of tracks; that is they are aligned with a
particular track pair, for example, long tracks providing a "full"
dose of the substance contained in the syringe 20. Off set from the
long track pair around the circumference of the internal surface of
the mid-body 13 is another shorter track pair 105 (not shown).
Rotating the main body and mid body relative to each other (for
example, rotating the main body 10 relative to the mid-body 13
clockwise looking from proximal to distal) will align the line 120
with the small indicator circle rather than the big indicator
circle in FIG. 4. This equates to selecting a small dose rather
than a full dose. Internally, the rotation of the main body portion
10 relative to the mid-body portion 13 causes rotation of the dose
adjuster rod 41 and hence rotation of the plunger 40 relative to
the mid-body 13 and consequently the pegs 104 are no longer aligned
with the long tracks 105 but now with the short tracks 105.
[0065] In this embodiment, the rotation of the two housing portions
10 and 13 relative to each other causes relative rotation of the
plunger head 102 and plunger 40 to the mid-body 13, whereas the
trigger button 52, and latch ring 110 rotate relative to the main
body 10; that is the latch ring 110 is fixed relative to the
mid-body 13 and does not rotate relative to the lockout shroud 100
and trigger button 52. Rotation of the main body 10, relative to
the mid-body 13 causes rotation of the plunger 40 since the
proximal end 43 of the dose adjuster rod 41 is connected to the
frame 46 of the main body 10.
[0066] In an alternative embodiment, the dose selector could be
provided as a separate part of the housing 2, whereby the rotation
of the selector acted directly on the proximal portion of the
plunger which then provided rotation of the distal portion of the
plunger relative to the housing.
[0067] Of course, the head 102 with the pegs 104 could be provided
at any suitable portion of the plunger or a separate component
configured to operate on the plunger and move with the plunger
relative to the housing 2--together with appropriate modifications
in relation to the co-operating tracks in the housing 2. Whilst the
co-operating tracks in the embodiment are provided in the wall of
the mid-body portion of the housing, the tracks could be provided
in any convenient manner, for example in a separate component
located within the housing.
[0068] In the embodiment of FIGS. 1 to 4, the dose selector relies
on pegs on the plunger located in one set of co-operating tracks,
selected from 2 or more sets of such co-operating tracks. In an
alternative embodiment the tracks are located on the plunger and
pegs, ribs or other protrusions are located on the housing or
otherwise arranged to co-operate with the tracks on the plunger so
as to provide the required co-operation with the tracks. Any
combination of tracks or protrusions is envisaged. The use of pegs
on the plunger and tracks or grooves on the housing wall, provides
a compact device.
[0069] When the device is triggered the latch ring 110 and plunger
40 all move axially in the distal direction. This movement also
serves to move the syringe carrier 82 and syringe so as to protrude
out of the needle guard 32 so that the skin of a user can be
punctured by the cannula 26.
[0070] In a further aspect of the invention, the syringe carrier 82
carries indicator markings to indicate that the injector device is
ready to be used or conversely that the device has already been
used and should be discarded. Before use the ready-for-use
indicator 83 (the tick mark on the distal portion of the syringe
carrier shown in FIG. 3) is visible through a window 131 in the
mid-body 13. In particular, the window 131 of the mid-body 13 is
located relative to the syringe carrier 82 such that the
ready-for-use indicator 83 can be seen through a distal portion of
the window 131 before use of the device. A cut out 132 is required
in the lockout shroud so that at least a portion of the syringe
carrier 82 can be seen through the window 131.
[0071] Following the two-step procedure described above for firing
the device, the syringe carrier 82 has moved relative to the
lockout shroud 100 and the mid-body 13. The ready-for-use indicator
83 can no longer be viewed through the window 131 and/or through
the cut-out 132 of the lockout shroud 100. On the other hand, a
"used" indicator 84 can now be seen through a proximal portion of
the window 131 and cutout 132.
[0072] Exemplary embodiments of the invention have been described
with reference to the drawings. Modifications will suggest
themselves to those skilled in the art without departing from the
scope of the invention as defined by the appended claims.
* * * * *